Preventing Synovial Joint Organ Failure: Multidisciplinary Tools, Mechanisms & Translation

An Xray of a high tibial osteotomy implant

Synovial Joint Failure

Project Summary

This project leverages a unique randomized clinical trial of surgical correction of abnormal knee loading that improved pain and cartilage health to define the biological basis of synovial joint organ failure. By linking molecular (synovial fluid proteomics), imaging (advanced MRI), and clinical outcome data, we will identify signatures that predict and track joint recovery at the tissue level.
Findings from this foundational dataset will seed a broader research program spanning the full spectrum of joint disease, from juvenile-onset to adult osteoarthritis, establishing which molecular and imaging signatures best align with outcomes and treatment response. This funding will build the evidence base and team capacity needed to drive future high-impact applications, with the ultimate goal of enabling earlier detection of joint failure, rigorous biomarker validation, and the development of non-surgical therapies to slow or prevent osteoarthritis progression.

Project Duration

April 2026 – March 2028       Amount: $50,000

Team Leads

Tom Appleton (Physiology & Pharmacology) & Matthew Teeter (Medical Biophysics)

Team Members

• Biomedical: Appleton (immunology, bioinformatics), Grol (physiology).
• Engineering/Physical Sciences: Birmingham (biomechanics), Fenster (imaging), Atkinson (MRI analytics).
• Clinical & Health Services: Appleton (rheumatology), Giffin, Lanting (orthopedic surgery).
• Population & Community Health: Bryant (epidemiology, trials), MacDermid (outcome measures)

Completed Milestones

Completed Milestones

  •  Planning Meeting - Design Discussion - June 2026

Featured Stories

Featured Stories

  •